Pacific Ridge Capital Partners’s Sensus Healthcare SRTS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.38M Sell
789,675
-6,397
-0.8% -$22.4K 0.43% 63
2026
Q1
$3.17M Buy
796,072
+97,438
+14% +$433K 0.69% 54
2025
Q4
$2.78M Buy
698,634
+125,245
+22% +$464K 0.61% 57
2025
Q3
$1.8M Buy
573,389
+118,628
+26% +$466K 0.4% 64
2025
Q2
$2.16M Buy
454,761
+340,261
+297% +$1.59M 0.52% 62
2025
Q1
$542K Buy
+114,500
New +$667K 0.14% 113

Other funds holding SRTS

Pacific Ridge Capital Partners's SRTS Position: Q2 2026 in Review

Pacific Ridge Capital Partners reduced its Sensus Healthcare (SRTS) stake by 0.8% in Q2 2026, selling an estimated $22.4K and leaving 789,675 shares worth $2.38M. The position accounts for 0.43% of the portfolio, ranked #63.

Pacific Ridge Capital Partners first reported a position in SRTS in Q1 2025 and has held it in 6 quarters since. The position peaked at $3.17M in Q1 2026. 38 funds tracked by Wall St. Rank hold SRTS as of Q2 2026.

  • Pacific Ridge Capital Partners held 789,675 shares of Sensus Healthcare worth $2.38M as of Q2 2026.
  • Pacific Ridge Capital Partners sold 6,397 Sensus Healthcare shares in Q2 2026, an estimated $22.4K.
  • Sensus Healthcare made up 0.43% of Pacific Ridge Capital Partners's portfolio in Q2 2026, its #63 holding.
  • Pacific Ridge Capital Partners first reported a position in Sensus Healthcare in Q1 2025 and has held it in 6 quarters since.
  • Pacific Ridge Capital Partners's Sensus Healthcare position peaked at $3.17M in Q1 2026.
  • 38 funds tracked by Wall St. Rank held Sensus Healthcare as of Q2 2026.

Based on Pacific Ridge Capital Partners's 13F filing for Q2 2026, filed 12 Aug 2026.